Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05353452

Collaborative Care in Posttraumatic Epilepsy

Collaborative Care for Anxiety and Depression in Posttraumatic Epilepsy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to usual neurology care among a total of 60 adults with post-traumatic epilepsy.

Detailed description

The study will compare collaborative care versus usual care among N=60 adults with post-traumatic epilepsy and anxiety and/or depression symptoms in Veterans Administration (N=20) and civilian university (N=40) settings at the Salisbury VA and Atrium Health Neurology. This single-blind study will evaluate effectiveness and implementation of a remotely-delivered, 24-week team-delivered collaborative care intervention, with features adapted from VA Primary Care Mental Health Integration and Whole Health, as well as an existing Family Medicine Collaborative Care Program at AHWFB.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeurology Based Collaborative CareTwenty-four week, evidence-based remote collaborative care model initiated around the time of a neurology visit. The collaborative care team roles include the care manager, psychiatrist, and psychologist/social worker who interact with the patient participant and the patient's neurologist.
BEHAVIORALSOC Neurological careUsual neurology care means ongoing, epilepsy provider-recommended clinic visits, prescriptions, testing and referrals from their epilepsy provider. Mental health referrals or prescribing of antidepressants may potentially occur in this group; these types of interventions will be tracked at outcome assessments.

Timeline

Start date
2023-04-30
Primary completion
2026-05-01
Completion
2026-07-01
First posted
2022-04-29
Last updated
2026-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05353452. Inclusion in this directory is not an endorsement.